149 related articles for article (PubMed ID: 32910990)
1. Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway.
Ibáñez-Cabellos JS; Seco-Cervera M; Picher-Latorre C; Pérez-Machado G; García-Giménez JL; Pallardó FV
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118845. PubMed ID: 32910990
[TBL] [Abstract][Full Text] [Related]
2. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
[TBL] [Abstract][Full Text] [Related]
3. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
[TBL] [Abstract][Full Text] [Related]
4. Pseudouridylation defect due to
Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
[TBL] [Abstract][Full Text] [Related]
6. Advances in the understanding of dyskeratosis congenita.
Walne AJ; Dokal I
Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
[TBL] [Abstract][Full Text] [Related]
7. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
8. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Vulliamy TJ; Dokal I
Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
[TBL] [Abstract][Full Text] [Related]
9. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
[TBL] [Abstract][Full Text] [Related]
10. A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization.
Pereboom TC; van Weele LJ; Bondt A; MacInnes AW
Blood; 2011 Nov; 118(20):5458-65. PubMed ID: 21921046
[TBL] [Abstract][Full Text] [Related]
11. Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.
Trahan C; Martel C; Dragon F
Hum Mol Genet; 2010 Mar; 19(5):825-36. PubMed ID: 20008900
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.
Zhang Y; Morimoto K; Danilova N; Zhang B; Lin S
PLoS One; 2012; 7(1):e30188. PubMed ID: 22299032
[TBL] [Abstract][Full Text] [Related]
13. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
14. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
15. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and genetic features of dyskeratosis congenital with bone marrow failure in eight patients].
Wan Y; An WB; Zhang JY; Zhang JL; Zhang RR; Zhu S; Chang LX; Zhang YC; Liu F; Yang WY; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):216-20. PubMed ID: 27033759
[TBL] [Abstract][Full Text] [Related]
17. [Dyskeratosis congenita, a disease caused by defective telomere maintenance].
Hoareau-Aveilla C; Henry Y; Leblanc T
Med Sci (Paris); 2008 Apr; 24(4):390-8. PubMed ID: 18405638
[TBL] [Abstract][Full Text] [Related]
18. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
19. Dyskeratosis congenita as a disorder of telomere maintenance.
Nelson ND; Bertuch AA
Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
[TBL] [Abstract][Full Text] [Related]
20. Detection of mutations in TERT, the genes for telomerase reverse transcriptase, in Indian patients of aplastic anaemia: a pilot study.
Mehta S; Krishnamohan M; Gulati S; Sharmat N; Vashishtha P; Singh I
J Assoc Physicians India; 2014 Oct; 62(10):13-7. PubMed ID: 25906515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
